Abstract
The neurobiology of aggression in Alzheimer's Disease (AD) remains unknown. The objective of this study was to determine if altered central noradrenergic (NE) responsiveness is related to aggression in AD. Fifteen institutionalized, non-depressed elderly (11 males, four females, mean age 81.5 +/- 5.5) with probable AD, severe cognitive impairment (MMSE mean 3.3 +/- 4.6) and significant behavioral disturbances (Neuropsychiatric Inventory (NPI) score > or = 8) were studied. Growth Hormone (GH) response to clonidine challenge (5 microg/kg) was used as an index of central alpha(2)-adrenergic function. When patients were divided into those with preserved GH response (GH maximum change from baseline > 0, n = 6) and those with blunted GH response (GH maximum change from baseline < or = 0, n = 9) there were significant differences in levels of aggression as measured by the Cohen-Mansfield Agitation Inventory (CAMI) physical aggression subscale (p = .026). Patients with blunted GH response also had significantly higher levels of aggression against others on the retrospective Overt Aggression Scale (p = 0.027). Certain types of physically aggressive behaviors are associated with a blunted GH response to clonidine challenge. This finding ...Continue Reading
References
Sep 1, 1975·Archives of Neurology·V C HachinskiL Symon
Nov 1, 1991·Psychiatry Research·E F CoccaroL J Siever
Sep 15, 1989·The Journal of Comparative Neurology·V Chan-Palay, E Asan
Mar 1, 1989·Psychiatry Research·C GillesJ Mendlewicz
Oct 1, 1986·Journal of the American Geriatrics Society·J Cohen-Mansfield, N Billig
Sep 1, 1986·Biological Psychiatry·T W UhdeR M Post
Jan 1, 1982·Psychopharmacology·E ErikssonK Modigh
Oct 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·I B GlassS Dawling
Sep 1, 1984·Mechanisms of Ageing and Development·I Gil-AdZ Laron
Jul 1, 1984·Neurology·G McKhannE M Stadlan
Apr 1, 1984·Archives of General Psychiatry·M A RaskindD C Jimerson
Feb 1, 1982·Journal of Neurology, Neurosurgery, and Psychiatry·D M MannJ Hawkes
Jul 16, 1982·JAMA : the Journal of the American Medical Association·P V RabinsM J Lucas
Feb 1, 1982·Neurology·W BondareffM Roth
Sep 1, 1995·Archives of General Psychiatry·E R PeskindM A Raskind
Dec 1, 1994·Neurology·J L CummingsJ Gornbein
Feb 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R MongeauP Blier
Feb 28, 1996·Psychiatry Research·S ValdiviesoJ P Macher
Jan 15, 1997·Psychiatry Research·G GerraF Brambilla
Sep 24, 1999·Biological Psychiatry·M A RaskindD S Goldstein
Dec 13, 2000·Brain Research. Molecular Brain Research·P SzotM A Raskind
Feb 24, 2001·The Journal of Neuropsychiatry and Clinical Neurosciences·K L LanctôtP Mazzotta
Mar 21, 2002·Biological Psychiatry·Kim L MatthewsPaul T Francis
Mar 14, 2003·Archives of Neurology·Chris ZarowHelena C Chui
Citations
Aug 19, 2014·BioMed Research International·Xiao-Ling LiLan Tan
Sep 1, 2007·Age·Eric R BravermanKenneth Blum
Sep 1, 2005·Current Neurology and Neuroscience Reports·Dag AarslandClive Ballard
Mar 2, 2006·Gerontology·Robert T RubinR Kenneth Czambel
Mar 10, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kristina GotovacFran Borovečki
Jun 12, 2008·Experimental Neurology·Krista L LanctôtLana S Rothenburg
May 21, 2010·Psychiatry Research·Emil F Coccaro, Richard J Kavoussi
Jun 28, 2011·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Anna LennquistLars Förlin
Jun 26, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Myuri RuthirakuhanNathan Herrmann
May 5, 2018·The Cochrane Database of Systematic Reviews·Myuri T RuthirakuhanKrista L Lanctôt
Apr 9, 2019·Drugs & Aging·Mehnaz AhmedNathan Herrmann